1. Home
  2. RAPT vs FDSB Comparison

RAPT vs FDSB Comparison

Compare RAPT & FDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • FDSB
  • Stock Information
  • Founded
  • RAPT 2015
  • FDSB 1926
  • Country
  • RAPT United States
  • FDSB United States
  • Employees
  • RAPT N/A
  • FDSB N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • FDSB
  • Sector
  • RAPT Health Care
  • FDSB
  • Exchange
  • RAPT Nasdaq
  • FDSB NYSE
  • Market Cap
  • RAPT 59.1M
  • FDSB 70.0M
  • IPO Year
  • RAPT 2019
  • FDSB N/A
  • Fundamental
  • Price
  • RAPT $1.20
  • FDSB $12.91
  • Analyst Decision
  • RAPT Hold
  • FDSB
  • Analyst Count
  • RAPT 10
  • FDSB 0
  • Target Price
  • RAPT $6.00
  • FDSB N/A
  • AVG Volume (30 Days)
  • RAPT 9.1M
  • FDSB 28.4K
  • Earning Date
  • RAPT 03-06-2025
  • FDSB 02-15-2025
  • Dividend Yield
  • RAPT N/A
  • FDSB N/A
  • EPS Growth
  • RAPT N/A
  • FDSB N/A
  • EPS
  • RAPT N/A
  • FDSB N/A
  • Revenue
  • RAPT N/A
  • FDSB $10,898,681.00
  • Revenue This Year
  • RAPT N/A
  • FDSB N/A
  • Revenue Next Year
  • RAPT N/A
  • FDSB N/A
  • P/E Ratio
  • RAPT N/A
  • FDSB N/A
  • Revenue Growth
  • RAPT N/A
  • FDSB N/A
  • 52 Week Low
  • RAPT $0.79
  • FDSB $9.85
  • 52 Week High
  • RAPT $27.35
  • FDSB $13.40
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 43.92
  • FDSB N/A
  • Support Level
  • RAPT $1.07
  • FDSB N/A
  • Resistance Level
  • RAPT $1.29
  • FDSB N/A
  • Average True Range (ATR)
  • RAPT 0.17
  • FDSB 0.00
  • MACD
  • RAPT -0.04
  • FDSB 0.00
  • Stochastic Oscillator
  • RAPT 15.43
  • FDSB 0.00

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About FDSB FIFTH DISTRICT BANCORP INC.

Fifth District Bancorp inc is a holding company of Fifth District. Fifth District portfolio consists primarily of fixed-rate one- to four-family residential mortgage loans also originate construction loans, home equity loans, home equity lines of credit, land loans, and share loans (loans secured by deposit accounts at Fifth District) and purchase commercial business loans. The company offer a variety of deposit accounts including checking accounts, money market accounts, and certificates of deposit. In addition, it offers electronic banking services including mobile banking, on-line banking, telephone banking, bill pay, and electronic funds transfer via SmartPay..

Share on Social Networks: